Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
148 days remaining
NOA E-Mailed - SOU Required
Due Date
December 03, 2025
Extension Available
Until June 03, 2026
Application History
12 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 3, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 13, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 13, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Mar 13, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Mar 13, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Mar 13, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Mar 10, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 6, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 6, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of immuno deficiency disorders; intravenous immunoglobulins for use in the treatment of immuno deficiency disorders and in immune replacement therapy; Pharmaceutical preparations for the treatment of dermatomyositis, inflammatory diseases and inflammatory conditions, muscle conditions and skin conditions; pharmaceutical preparations for the treatment of skin rash, weight loss, fever, lung conditions, light sensitivity, calcium deposits, and cardiovascular conditions; pharmaceutical preparations for the treatment of inflammatory myopathy and muscular conditions
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DM"